MEMBER'S LOGINX
| Invalid Username / Password | ||||||||
| Invalid Captcha | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Stock Quote
- Sector Info (List of nifty midcap liquid 15 Stocks)
- List of NIFTY Midcap Liquid 15 Stocks
List of NIFTY Midcap Liquid 15
Stocks 
Here are the latest stock price details of the stocks in the NIFTY Midcap Liquid 15. For more detailed updates, check the latest NIFTY Midcap Liquid 15 stock results and see the latest NIFTY Midcap Liquid 15 long term chart.
India's Capex Comeback: Explore Small Cap Stock Opportunities
| SCRIP | BSE PRICE (Rs) | NSE PRICE (Rs) | CHART | MORE INFO |
|---|---|---|---|---|
| GLENMARK PHARMA | 1,042.10 2.21% | 1,042.45 2.25% |
|
More Info
|
| INDRAPRASTHA GAS | 444.15 0.84% | 444.00 0.79% |
|
More Info
|
| BHARAT FORGE | 1,490.15 0.77% | 1,490.05 0.73% |
|
More Info
|
| VOLTAS | 1,296.40 0.60% | 1,296.70 0.65% |
|
More Info
|
| TVS MOTORS | 2,190.75 0.30% | 2,191.50 0.32% |
|
More Info
|
| REC | 544.50 0.13% | 544.85 0.17% |
|
More Info
|
| S&P BSE SENSEX | 74,005.94 0.12% | Not Listed |
|
More Info
|
| MINDTREE | 3,433.35 0.09% | 3,433.85 0.14% |
|
More Info
|
| APOLLO HOSPITALS | 5,956.95 0.08% | 5,953.95 0.02% |
|
More Info
|
| EXIDE INDUSTRIES | 476.30 0.02% | 476.35 0.01% |
|
More Info
|
| NIFTY MIDCAP LIQUID 15 | Not Listed | 11,567.50 0.46% |
|
More Info
|
| NIFTY 50 | Not Listed | 22,502.00 0.16% |
|
More Info
|
| JUBILANT FOODWORKS | 469.60 -0.14% | 469.40 -0.28% |
|
More Info
|
| FEDERAL BANK | 163.75 -0.18% | 163.85 0.00% |
|
More Info
|
| LIC HOUSING | 645.70 -0.90% | 644.85 -1.10% |
|
More Info
|
BSE prices: May 18, 2024 (Close) NSE prices: May 18, 2024 (Close)
NIFTY Midcap Liquid 15 Stocks Update
The NIFTY MIDCAP LIQUID 15 Index was at 11,567.5 (up 0.5%). The index is up 0.0% over the last 30 days. And over the last 1 year, it has gained 0.0%.
Within the NIFTY Midcap Liquid 15 Index, the top gainers were GLENMARK PHARMA (up 2.2%) and INDRAPRASTHA GAS (up 0.8%). On the other hand, LIC HOUSING (down 0.9%) and FEDERAL BANK (down 0.2%) were among the top losers.
Meanwhile, the benchmark NIFTY 50 was at 22,502.0 (up 0.2%).
Before you go, here are the upcoming corporate actions for NIFTY Midcap Liquid 15 stocks.
Upcoming Quarterly Results
| COMPANY | PRICE (Rs) | CHANGE (%) | RESULT DATE |
|---|---|---|---|
| JUBILANT FOODWORKS | 469.60 | -0.14 | 22-May-24 |
| GLENMARK PHARMA | 1,042.10 | 2.21 | 24-May-24 |
| APOLLO HOSPITALS | 5,956.95 | 0.08 | 30-May-24 |
List of All Upcoming Quarterly Results
FAQs
What is Nifty midcap liquid 15?
The Nifty midcap liquid 15 index measures the performance of the liquid midcap stocks that are easily replicable and tradable, with maximum weight of a single stock capped at 15%. All the index constituents have derivatives traded on them.
The number of companies present in the index remains fixed at 15.
To filter the best quality stocks from the Nifty midcap liquid 15 index, check out Equitymaster's Indian stock screener. This screener also allows you to screen stocks based on your own criteria.
Also check out our detailed guide on the best midcap stocks to buy in India.
Which are the top Nifty midcap liquid 15 companies?
Based on marketcap, these are the top 5 companies in the Nifty midcap liquid 15 index:
- #1 REC
- #2 TVS MOTORS
- #3 APOLLO HOSPITALS
- #4 BHARAT FORGE
- #5 VOLTAS
You can see the full list of the Nifty Midcap Liquid 15 stocks here.
And for a fundamental analysis of the above companies, check out Equitymaster's Indian stock screener which has a separate screen for top midcap companies in India.
What is the price of Nifty midcap liquid 15 index live today?
The NIFTY MIDCAP LIQUID 15 last traded at 11,567.5. It was up 0.5% over its previous close.
Within the NIFTY Midcap Liquid 15 Index, the top gainers were GLENMARK PHARMA (up 2.2%) and INDRAPRASTHA GAS (up 0.8%). On the other hand, LIC HOUSING (down 0.9%) and FEDERAL BANK (down 0.2%) were among the top losers.
For more, please visit the Nifty midcap liquid 15 Live Chart.
Can we buy the Nifty midcap liquid 15 index?
The Nifty midcap liquid 15 index is a collection of stocks and not a security that is traded on any stock exchange. Hence, we cannot buy the index directly.
However, as there are only 15 stocks in the index, investors can easily replicate the index by buying the entirety of the 15 stocks in the same weightage.
One can also invest in index funds or ETFs representing the index or buy future and options for the same.
Which are the other important indices one should track?
Well, it depends on what your goals are.
Having said that, the two key indices to track are the BSE Sensex which contains the list of BSE 30 stocks and the NSE Nifty which contains the list of NSE 50 stocks. However, these two indices are considered to be too narrow by some, since they only track 30 and 50 stocks, respectively.
For broader tracking, you could use the BSE 200, BSE 500 or even the NSE 500 index.
Some popular market cap based indices include BSE Smallcap index and BSE Midcap index, among others.
Today's Market
![Sensex Tops 74,000 in Mock Trading Session Today | HAL, Mazagon Dock, Bharat Dynamics Surge 5% | All Sectoral Indices in Green]()
Sensex Tops 74,000 in Mock Trading Session Today | HAL, Mazagon Dock, Bharat Dynamics Surge 5% | All Sectoral Indices in Green(Closing)
Indian share markets ended the mock trading session on a positive note tracking strong global peers and FII inflows.
ABOUT EQUITYMASTER
Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.
PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
- Multibagger Penny Stocks
- Basics of Value Investing
- Benjamin Graham
- How to Invest in Gold
- How to Invest in Silver
- Best Stocks to Buy Today
- Best Small-cap Stocks to Buy
- Best Bluechip Stocks to Buy
- Guide to Penny Stocks
- How to Invest in the Share Market
- Warren Buffett - The Value Investor
- Pick the Best Multibagger Stocks
TRENDING TOPICS
Copyright © Equitymaster Agora Research Private Limited.
Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap
Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407
Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com
LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.
All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.
Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.